These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 38319453)
41. Overexpression of PER3 Inhibits Self-Renewal Capability and Chemoresistance of Colorectal Cancer Stem-Like Cells via Inhibition of Notch and β-Catenin Signaling. Zhang F; Sun H; Zhang S; Yang X; Zhang G; Su T Oncol Res; 2017 May; 25(5):709-719. PubMed ID: 27983919 [TBL] [Abstract][Full Text] [Related]
42. MiR-148a suppressed cell invasion and migration via targeting WNT10b and modulating β-catenin signaling in cisplatin-resistant colorectal cancer cells. Shi L; Xi J; Xu X; Peng B; Zhang B Biomed Pharmacother; 2019 Jan; 109():902-909. PubMed ID: 30551544 [TBL] [Abstract][Full Text] [Related]
43. Possible Role of Cancer Stem Cells in Colorectal Cancer Metastasizing to the Liver. Jiao ZY; Cao HT; Li YM Curr Stem Cell Res Ther; 2016; 11(5):440-3. PubMed ID: 26832139 [TBL] [Abstract][Full Text] [Related]
44. Anti-EGFR antibody sensitizes colorectal cancer stem-like cells to Fluorouracil-induced apoptosis by affecting autophagy. Feng Y; Gao S; Gao Y; Wang X; Chen Z Oncotarget; 2016 Dec; 7(49):81402-81409. PubMed ID: 27833077 [TBL] [Abstract][Full Text] [Related]
45. Clinical Implications of Colorectal Cancer Stem Cells in the Age of Single-Cell Omics and Targeted Therapies. Frank MH; Wilson BJ; Gold JS; Frank NY Gastroenterology; 2021 May; 160(6):1947-1960. PubMed ID: 33617889 [TBL] [Abstract][Full Text] [Related]
46. LGR5 promotes cancer stem cell traits and chemoresistance in cervical cancer. Cao HZ; Liu XF; Yang WT; Chen Q; Zheng PS Cell Death Dis; 2017 Sep; 8(9):e3039. PubMed ID: 28880275 [TBL] [Abstract][Full Text] [Related]
47. The glycosyltransferase ST6Gal-I is enriched in cancer stem-like cells in colorectal carcinoma and contributes to their chemo-resistance. Cui H; Yang S; Jiang Y; Li C; Zhao Y; Shi Y; Hao Y; Qian F; Tang B; Yu P Clin Transl Oncol; 2018 Sep; 20(9):1175-1184. PubMed ID: 29423671 [TBL] [Abstract][Full Text] [Related]
48. The molecular chaperone apolipoprotein J/clusterin as a sensor of oxidative stress: implications in therapeutic approaches - a mini-review. Trougakos IP Gerontology; 2013; 59(6):514-23. PubMed ID: 23689375 [TBL] [Abstract][Full Text] [Related]
49. Heterogeneity of Colon Cancer Stem Cells. Hirata A; Hatano Y; Niwa M; Hara A; Tomita H Adv Exp Med Biol; 2019; 1139():115-126. PubMed ID: 31134498 [TBL] [Abstract][Full Text] [Related]
50. Emerging Prospects for the Study of Colorectal Cancer Stem Cells using Patient-derived Organoids. Ding L; Yang Y; Lu Q; Cao Z; Weygant N Curr Cancer Drug Targets; 2022; 22(3):195-208. PubMed ID: 35078398 [TBL] [Abstract][Full Text] [Related]
51. Slow-Cycling Cancer Stem Cells Regulate Progression and Chemoresistance in Colon Cancer. Shiokawa D; Sakai H; Ohata H; Miyazaki T; Kanda Y; Sekine S; Narushima D; Hosokawa M; Kato M; Suzuki Y; Takeyama H; Kambara H; Nakagama H; Okamoto K Cancer Res; 2020 Oct; 80(20):4451-4464. PubMed ID: 32816913 [TBL] [Abstract][Full Text] [Related]
52. Role of doublecortin-like kinase 1 and leucine-rich repeat-containing G-protein-coupled receptor 5 in patients with stage II/III colorectal cancer: Cancer progression and prognosis. Kang XL; He LR; Chen YL; Wang SB World J Gastroenterol; 2020 Nov; 26(43):6853-6866. PubMed ID: 33268966 [TBL] [Abstract][Full Text] [Related]
54. Gel-Free 3D Tumoroids with Stem Cell Properties Modeling Drug Resistance to Cisplatin and Imatinib in Metastatic Colorectal Cancer. Sogawa C; Eguchi T; Namba Y; Okusha Y; Aoyama E; Ohyama K; Okamoto K Cells; 2021 Feb; 10(2):. PubMed ID: 33562088 [TBL] [Abstract][Full Text] [Related]
55. Exosomal Wnt-induced dedifferentiation of colorectal cancer cells contributes to chemotherapy resistance. Hu YB; Yan C; Mu L; Mi YL; Zhao H; Hu H; Li XL; Tao DD; Wu YQ; Gong JP; Qin JC Oncogene; 2019 Mar; 38(11):1951-1965. PubMed ID: 30390075 [TBL] [Abstract][Full Text] [Related]
56. Liposomal co-delivery-based quantitative evaluation of chemosensitivity enhancement in breast cancer stem cells by knockdown of GRP78/CLU. Samson AAS; Park S; Kim SY; Min DH; Jeon NL; Song JM J Liposome Res; 2019 Mar; 29(1):44-52. PubMed ID: 29262741 [TBL] [Abstract][Full Text] [Related]
57. Clusterin is a potential molecular predictor for ovarian cancer patient's survival: targeting clusterin improves response to paclitaxel. Hassan MK; Watari H; Han Y; Mitamura T; Hosaka M; Wang L; Tanaka S; Sakuragi N J Exp Clin Cancer Res; 2011 Dec; 30(1):113. PubMed ID: 22185350 [TBL] [Abstract][Full Text] [Related]
58. Role and molecular mechanism of stem cells in colorectal cancer initiation. Wang MY; Qiu YH; Cai ML; Zhang CH; Wang XW; Liu H; Chen Y; Zhao WL; Liu JB; Shao RG J Drug Target; 2020 Jan; 28(1):1-10. PubMed ID: 31244351 [TBL] [Abstract][Full Text] [Related]
59. An integrative gene expression signature analysis identifies CMS4 KRAS-mutated colorectal cancers sensitive to combined MEK and SRC targeted therapy. Yang M; Davis TB; Pflieger L; Nebozhyn MV; Loboda A; Wang H; Schell MJ; Thota R; Pledger WJ; Yeatman TJ BMC Cancer; 2022 Mar; 22(1):256. PubMed ID: 35272617 [TBL] [Abstract][Full Text] [Related]
60. Verteporfin blocks Clusterin which is required for survival of gastric cancer stem cell by modulating HSP90 function. Xiong J; Wang S; Chen T; Shu X; Mo X; Chang G; Chen JJ; Li C; Luo H; Lee JD Int J Biol Sci; 2019; 15(2):312-324. PubMed ID: 30745823 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]